U-Blot® Research Grade Anti-Human MET/c-Met/HGFR (CE-355621)Cat. No. WA2116$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human MET/c-Met/HGFR (CE-355621)Cat. No. WA2116
U-Blot® Research Grade Anti-Human MET/c-Met/HGFR (CBT-161)Cat. No. WA2115
U-Blot® Research Grade Anti-Human MET/c-Met/HGFR (ARGX-111)Cat. No. WA2114
U-Blot® Research Grade Anti-Human MET/c-Met/HGFR (ABBV-400)Cat. No. WA2113
U-Blot® Research Grade Anti-Human MERTK/MER Antibody (RGX-019)Cat. No. WA2112
U-Blot® Research Grade Anti-Human MDM2 (OM-301)Cat. No. WA2111
U-Blot® Research Grade Anti-Human MDM2 (NMC-001)Cat. No. WA2110
U-Blot® Research Grade Anti-Human MASP2 (CM338)Cat. No. WA2109
U-Blot® Research Grade Anti-Human MAPT/Tau/PHF-tau (TBL-100)Cat. No. WA2108
U-Blot® Research Grade Anti-Human MAPT/Tau/PHF-tau (PNT001)Cat. No. WA2107
U-Blot® Research Grade Anti-Human MAPT/Tau/PHF-tau (E2814)Cat. No. WA2106
U-Blot® Research Grade Anti-Human MAPT/Tau/PHF-tau (DC8E8)Cat. No. WA2105